专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

81. 发明申请

US20060211149A1 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance 审中-公开
公开(公告)号：US20060211149A1
公开(公告)日：2006-09-21
申请号：US11439813
申请日：2006-05-23
申请人： George Jackowski , John Marshall
发明人： George Jackowski , John Marshall
IPC分类号： G01N33/543 , G01N33/00 , C07K16/26
CPC分类号： C07K14/78 , Y10T436/24 , Y10T436/255
摘要： The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of said at least one disease state relative to recognition of the presence and/or the absence of said biopolymer, predict disease risk assessment, and develop therapeutic avenues against said disease.

82. 发明申请

US20060211140A1 Protein biopolymer markers predictive of insulin resistance 审中-公开
公开(公告)号：US20060211140A1
公开(公告)日：2006-09-21
申请号：US11437924
申请日：2006-05-19
申请人： George Jackowski , John Marshall
发明人： George Jackowski , John Marshall
IPC分类号： G01N33/543 , G01N33/00 , C07K16/26
CPC分类号： C07K14/775 , G01N33/6893 , Y10T436/24
摘要： The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of said at least one disease state relative to recognition of the presence and/or the absence of said biopolymer, predict disease risk assessment, and develop therapeutic avenues against said disease.

83. 发明申请

US20060211139A1 Protein biopolymer markers predictive of insulin resistance 审中-公开
公开(公告)号：US20060211139A1
公开(公告)日：2006-09-21
申请号：US11437919
申请日：2006-05-19
申请人： George Jackowski , John Marshall
发明人： George Jackowski , John Marshall
IPC分类号： G01N33/543 , G01N33/00 , C07K16/26
CPC分类号： C07K14/775 , G01N33/6893 , Y10T436/24
摘要： The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of said at least one disease state relative to recognition of the presence and/or the absence of said biopolymer, predict disease risk assessment, and develop therapeutic avenues against said disease.

84. 发明申请

US20060211138A1 Protein biopolymer markers predictive of insulin resistance 审中-公开
公开(公告)号：US20060211138A1
公开(公告)日：2006-09-21
申请号：US11437883
申请日：2006-05-19
申请人： George Jackowski , John Marshall
发明人： George Jackowski , John Marshall
IPC分类号： G01N33/543 , G01N33/00 , C07K16/26
CPC分类号： C07K14/775 , G01N33/6893 , Y10T436/24
摘要： The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of said at least one disease state relative to recognition of the presence and/or the absence of said biopolymer, predict disease risk assessment, and develop therapeutic avenues against said disease.

85. 发明申请

US20060194340A1 PROTEIN BIOPOLYMER MARKERS PREDICTIVE OF TYPE II DIABETES 失效
标题翻译：蛋白质生物标记物预测的II型糖尿病
公开(公告)号：US20060194340A1
公开(公告)日：2006-08-31
申请号：US09993393
申请日：2001-11-23
申请人： George Jackowski , John Marshall
发明人： George Jackowski , John Marshall
IPC分类号： G01N33/00 , G01N33/543 , C07K14/47
CPC分类号： C07K14/47 , Y10T436/24 , Y10T436/255
摘要： The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability-to characterize either the presence or absence of said at least one disease state relative to recognition of the presence and/or the absence of said biopolymer, predict disease risk assessment, and develop therapeutic avenues against said disease.
摘要翻译：本发明涉及使用组合的准备步骤与质谱法和飞行时间检测程序的组合，以使特定样品中可验证的生物聚合物的多样性最大化。然后，在这样一个样本中验证的生物聚合物队列参照其证明至少一种特定疾病状态的能力; 从而使得诊断者能够获得表征所述至少一种疾病状态的存在或不存在的能力，以相对于所述生物聚合物的存在和/或不存在的识别，预测疾病风险评估以及开发针对所述疾病的治疗途径。

86. 发明申请

US20060194337A1 FIBRONECTIN PRECURSOR BIOPOLYMER MARKERS INDICATIVE OF ALZHEIMER'S DISEASE 失效
标题翻译：阿奇霉素疾病表现的FIBRONECTIN PRECURSOR BIOPOLYMER MARKERS
公开(公告)号：US20060194337A1
公开(公告)日：2006-08-31
申请号：US09993289
申请日：2001-11-23
申请人： George Jackowski , John Marshall
发明人： George Jackowski , John Marshall
IPC分类号： G01N33/543 , C07K14/47
CPC分类号： C07K14/78 , G01N33/6896 , G01N2500/00 , G01N2800/2821 , Y10S435/81
摘要： The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of said at least one disease state relative to recognition of the presence and/or the absence of said biopolymer, predict disease risk assessment, and develop therapeutic avenues against said disease.
摘要翻译：本发明涉及使用组合的准备步骤与质谱法和飞行时间检测程序的组合，以使特定样品中可验证的生物聚合物的多样性最大化。然后，在这样一个样本中验证的生物聚合物队列参照其证明至少一种特定疾病状态的能力; 从而使得诊断者能够获得表征所述至少一种疾病状态的存在或不存在的能力，以相对于识别所述生物聚合物的存在和/或不存在，预测疾病风险评估以及开发针对所述疾病的治疗途径。

87. 发明申请

US20060160233A1 IG HEAVY CHAIN, IG KAPPA, IG LAMBDA BIOPOLYMER MARKERS PREDICTIVE OF ALZHEIMERS DISEASE 失效
标题翻译： IG HEAVY CHAIN，IG KAPPA，IG LAMBDA BIOPOLYMER MARKERS PREDICTIVE OF ALZHEIMERS DISEASE
公开(公告)号：US20060160233A1
公开(公告)日：2006-07-20
申请号：US09993304
申请日：2001-11-23
申请人： George Jackowski , John Marshall
发明人： George Jackowski , John Marshall
IPC分类号： G01N33/00 , C07K14/47
CPC分类号： C07K16/00 , C07K2317/50 , G01N33/6857 , G01N33/6896 , G01N2500/00 , G01N2800/2821 , Y10T436/24 , Y10T436/255
摘要： The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of said at least one disease state relative to recognition of the presence and/or the absence of said biopolymer, predict disease risk assessment, and develop therapeutic avenues against said disease.
摘要翻译：本发明涉及使用组合的准备步骤与质谱法和飞行时间检测程序的组合，以使特定样品中可验证的生物聚合物的多样性最大化。然后，在这样一个样本中验证的生物聚合物队列参照其证明至少一种特定疾病状态的能力; 从而使得诊断者能够获得表征所述至少一种疾病状态的存在或不存在的能力，以相对于识别所述生物聚合物的存在和/或不存在，预测疾病风险评估以及开发针对所述疾病的治疗途径。

88. 发明申请

US20060147095A1 Method and system for automatically capturing an image of a retina 审中-公开
标题翻译：自动捕获视网膜图像的方法和系统
公开(公告)号：US20060147095A1
公开(公告)日：2006-07-06
申请号：US11028726
申请日：2005-01-03
申请人： David Usher , Gregory Heacock , John Marshall , David Mueller
发明人： David Usher , Gregory Heacock , John Marshall , David Mueller
IPC分类号： G06K9/00
CPC分类号： G06K9/00604
摘要： A method and system capture an image of the interior of the eye, for example the retina and determine whether the captured image is sufficient to provide data for identifying an individual or animal before attempting to generate the identification data. If the captured image is not sufficient, the method and system automatically capture another image of the interior of the eye.
摘要翻译：一种方法和系统捕获眼睛内部的图像，例如视网膜，并且在尝试产生识别数据之前，确定捕获的图像是否足以提供用于识别个体或动物的数据。如果拍摄的图像不足，则该方法和系统自动捕获眼睛内部的另一图像。

89. 发明授权

US07052849B2 Protein biopolymer markers predictive of insulin resistance 失效
标题翻译：预测胰岛素抵抗的蛋白质生物聚合物标记
公开(公告)号：US07052849B2
公开(公告)日：2006-05-30
申请号：US09991627
申请日：2001-11-23
申请人： George Jackowski , John Marshall
发明人： George Jackowski , John Marshall
IPC分类号： G01N33/53
CPC分类号： C07K14/775 , G01N33/6893 , Y10T436/24
摘要： The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of at least one disease state relative to recognition of the presence and/or the absence of the biopolymer, predict disease risk assessment, and develop therapeutic avenues against the disease.
摘要翻译：本发明涉及使用组合的准备步骤与质谱法和飞行时间检测程序的组合，以使特定样品中可验证的生物聚合物的多样性最大化。然后，在这样一个样本中验证的生物聚合物队列参照其证明至少一种特定疾病状态的能力; 从而使得诊断者能够获得表征与识别生物聚合物的存在和/或不存在相关的至少一种疾病状态的存在或不存在的能力，预测疾病风险评估以及开发针对该疾病的治疗途径。

90. 发明申请

US20060084951A1 Low energy of excitation PDT compounds for treatment of ocular disease 审中-公开
标题翻译：低能激发PDT化合物治疗眼病
公开(公告)号：US20060084951A1
公开(公告)日：2006-04-20
申请号：US11240403
申请日：2005-09-30
申请人： Gregory Heacock , John Marshall , Paula Mahoney
发明人： Gregory Heacock , John Marshall , Paula Mahoney
IPC分类号： A61B18/18
CPC分类号： A61F9/0079 , A61F9/009 , A61F2009/00863 , A61F2009/00891 , A61N5/062
摘要： A photodynamic therapy includes a particular combination of a photosensitizer and light source for a photodynamic therapy used to treat ocular diseases. The photosensitizer has a peak excitation level when exposed to light of a given wavelength where the wavelength of light is absorbed at a particular location of the eye to be treated. The light source has a wavelength within the excitation range of the photosensitizer and matched to the location of the diseased eye tissue. The light source also has an irradiance level and energy level that is effective for therapy but at levels below the maximum permissible exposure level.
摘要翻译：光动力疗法包括用于治疗眼部疾病的光动力疗法的光敏剂和光源的特定组合。当光敏剂暴露于给定波长的光，其中光的波长被吸收在待治疗的眼睛的特定位置时，光敏剂具有峰值激发水平。光源具有在光敏剂的激发范围内的波长，并与病眼组织的位置相匹配。光源还具有对治疗有效的辐照度水平和能量水平，但水平低于最大允许暴露水平。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式